Fennec Banks On EMA’s Seldom-Used PUMA For Sodium Thiosulfate
Fennec Pharmaceuticals says that its new formulation of sodium thiosulfate for preventing cisplatin-induced hearing loss in children targets a critical unmet medical need.
You may also be interested in...
Mithra says its new oral contraceptive could be a major breakthrough in a “space where there hasn’t been any innovation in decades."
The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.